Brick & Kyle, Associates Buys CVS Health Corp, Chevron Corp, iShares TIPS Bond, Sells Zimmer Biomet Holdings Inc, GlaxoSmithKline PLC, Bristol-Myers Squibb Company

• New Purchases: CVS,
• Added Positions: CVX, TIP, FDX, VTI, AAPL, GOOGL, MO, RTN, EOI, UTX, NVDA, NIE, AMGN, BX, BAC, MU, FDD, HON,
• Reduced Positions: ABBV, VB, PFE, ITW, PG, XLF, EMR, D, VZ, V, JNJ, BDJ, MCD, MET, T, XOM, GOOG, ARKW, AWF, WM,
• Sold Out: ZBH, GSK, BMY, AMLP, DSL, HSY, PFF, SLB, CELG, NVG, NBB, NQP, MMM, NXJ, AVGO, JHS, RCS, EXAS, EIM, BTT, QTWO, GIS, JQC, VNQ, PCI, IBM, LH, NSL, PIM, PPT,

For the details of Brick & Kyle, Associates's stock buys and sells, go to https://www.gurufocus.com/guru/brick+%26+kyle%2C+associates/current-portfolio/portfolioportfolio

1. Amazon.com Inc (AMZN) - 3,624 shares, 6.66% of the total portfolio. Shares added by 0.39%
2. Microsoft Corp (MSFT) - 43,446 shares, 5.56% of the total portfolio. Shares reduced by 0.67%
3. Apple Inc (AAPL) - 24,122 shares, 4.54% of the total portfolio. Shares added by 2.66%
4. Merck & Co Inc (MRK) - 51,196 shares, 4.07% of the total portfolio. Shares reduced by 0.34%
5. The Walt Disney Co (DIS) - 30,097 shares, 3.98% of the total portfolio. Shares added by 0.13%

Brick & Kyle, Associates initiated holding in CVS Health Corp. The purchase prices were between $52.13 and $57.33, with an estimated average price of $53.82. The stock is now traded at around $56.23. The impact to a portfolio due to this purchase was 3.48%. The holding were 67,425 shares as of .

Brick & Kyle, Associates added to a holding in Chevron Corp by 37.32%. The purchase prices were between $113.85 and $126.68, with an estimated average price of $120.87. The stock is now traded at around $124.14. The impact to a portfolio due to this purchase was 0.56%. The holding were 17,734 shares as of .

Brick & Kyle, Associates added to a holding in iShares TIPS Bond by 266.13%. The purchase prices were between $112.34 and $115.84, with an estimated average price of $113.7. The stock is now traded at around $115.17. The impact to a portfolio due to this purchase was 0.2%. The holding were 6,993 shares as of .

Brick & Kyle, Associates added to a holding in Vanguard Total Stock Market by 47.58%. The purchase prices were between $140.41 and $150.7, with an estimated average price of $147.25. The stock is now traded at around $152.11. The impact to a portfolio due to this purchase was 0.14%. The holding were 2,956 shares as of .

Brick & Kyle, Associates added to a holding in Eaton Vance Enhanced Equity Income Fund by 22.22%. The purchase prices were between $13.93 and $15.03, with an estimated average price of $14.69. The stock is now traded at around $15.25. The impact to a portfolio due to this purchase was 0.05%. The holding were 17,975 shares as of .

Brick & Kyle, Associates sold out a holding in Zimmer Biomet Holdings Inc. The sale prices were between $112.14 and $128.84, with an estimated average price of $120.53.

Brick & Kyle, Associates sold out a holding in GlaxoSmithKline PLC. The sale prices were between $38.64 and $41.88, with an estimated average price of $40.14.

Brick & Kyle, Associates sold out a holding in Bristol-Myers Squibb Company. The sale prices were between $44.62 and $49.34, with an estimated average price of $46.57.

Brick & Kyle, Associates sold out a holding in Alerian MLP. The sale prices were between $9.57 and $10.07, with an estimated average price of $9.81.

Brick & Kyle, Associates sold out a holding in DoubleLine Income Solutions Fund. The sale prices were between $19.43 and $20.44, with an estimated average price of $20.16.

Brick & Kyle, Associates sold out a holding in The Hershey Co. The sale prices were between $113.84 and $138.32, with an estimated average price of $126.94.